Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders

Abstract Purpose Poor ovarian response (POR) is a big challenge for in vitro fertilization. The traditional Chinese medicine, Cai’s Prescription of Tonifying Kidney and Strengthening Vitals (Cai’s Prescription) has yielded satisfactory results for POR treatment clinically, but systematic scientific...

Full description

Bibliographic Details
Main Authors: Zheng Wang, Denghao Liu, Yonghong Nie, Qinhua Zhang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-024-01363-x
_version_ 1797273621517828096
author Zheng Wang
Denghao Liu
Yonghong Nie
Qinhua Zhang
author_facet Zheng Wang
Denghao Liu
Yonghong Nie
Qinhua Zhang
author_sort Zheng Wang
collection DOAJ
description Abstract Purpose Poor ovarian response (POR) is a big challenge for in vitro fertilization. The traditional Chinese medicine, Cai’s Prescription of Tonifying Kidney and Strengthening Vitals (Cai’s Prescription) has yielded satisfactory results for POR treatment clinically, but systematic scientific research of Cai’s Prescription is not well reported. This study aimed to investigate the clinical effect of Cai’s Prescription on poor ovarian responders and its biological mechanism. Methods Serum was collected from poor ovarian responders, and IL-1β, INFγ, FSH, E2 and AMH levels were analyzed by ELISA. Ovarian antral follicles were identified and counted using transvaginal ultrasound. The embryo quality grading were done on day 3 after retrieval. We used high-throughput sequencing of granulosa cells to investigate the gene transcription patterns of ovarian granulosa cells in poor ovarian responders after Cai’s Prescription pretreatment. The expression level of ARHGAP4 was analyzed by quantitative real-time PCR and western blot. The effects of ARHGAP4 for granulosa cells were analyzed by CCK-8 assay, annexin-V and PI staining, ELISA and western blot. The effects of Cai’s Prescription on the expression of PI3K-Akt pathway and apoptosis were analyzed by western blot. Results In this study, we found that Cai’s Prescription pretreatment had the tendency to improve the ovarian reserve function and could increase the number of high quality embryos for poor ovarian responders. Through high-throughput sequencing of mRNA in granulosa cells, we discovered ARHGAP4, which is a member of GTPase-activating proteins (GAPs) may be a candidate target for POR treatment. ARHGAP4 was significantly increased in poor ovarian responders and can be recovered after Cai’s Prescription pretreatment. Mechanically, combining the cell line model and clinical tissue samples, we found that ARHGAP4 can accelerate cell apoptosis and inflammation response in granulosa cells via PI3K-Akt signaling pathway. In addition, Cai’s Prescription pretreatment for three months significantly reduced the high level of ARHGAP4 in poor ovarian responders. Conclusion This study shows that the traditional Chinese medicine, Cai’s Prescription yielded satisfactory results for poor ovarian responders clinically and ARHGAP4 may be a candidate target for POR treatment.
first_indexed 2024-03-07T14:47:01Z
format Article
id doaj.art-c181b01f7a1e49e1a57f539e44772655
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-03-07T14:47:01Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-c181b01f7a1e49e1a57f539e447726552024-03-05T19:58:11ZengBMCJournal of Ovarian Research1757-22152024-02-0117111110.1186/s13048-024-01363-xCai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian respondersZheng Wang0Denghao Liu1Yonghong Nie2Qinhua Zhang3Department of Integrated Traditional Chinese and Western Medicine, Shanghai First Maternity and Infant Hospital, Tongji UniversityPrenatal Diagnosis Center, Shanghai First Maternity and Infant Hospital, Tongji UniversityDepartment of Integrated Traditional Chinese and Western Medicine, Shanghai First Maternity and Infant Hospital, Tongji UniversityDepartment of Integrated Traditional Chinese and Western Medicine, Shanghai First Maternity and Infant Hospital, Tongji UniversityAbstract Purpose Poor ovarian response (POR) is a big challenge for in vitro fertilization. The traditional Chinese medicine, Cai’s Prescription of Tonifying Kidney and Strengthening Vitals (Cai’s Prescription) has yielded satisfactory results for POR treatment clinically, but systematic scientific research of Cai’s Prescription is not well reported. This study aimed to investigate the clinical effect of Cai’s Prescription on poor ovarian responders and its biological mechanism. Methods Serum was collected from poor ovarian responders, and IL-1β, INFγ, FSH, E2 and AMH levels were analyzed by ELISA. Ovarian antral follicles were identified and counted using transvaginal ultrasound. The embryo quality grading were done on day 3 after retrieval. We used high-throughput sequencing of granulosa cells to investigate the gene transcription patterns of ovarian granulosa cells in poor ovarian responders after Cai’s Prescription pretreatment. The expression level of ARHGAP4 was analyzed by quantitative real-time PCR and western blot. The effects of ARHGAP4 for granulosa cells were analyzed by CCK-8 assay, annexin-V and PI staining, ELISA and western blot. The effects of Cai’s Prescription on the expression of PI3K-Akt pathway and apoptosis were analyzed by western blot. Results In this study, we found that Cai’s Prescription pretreatment had the tendency to improve the ovarian reserve function and could increase the number of high quality embryos for poor ovarian responders. Through high-throughput sequencing of mRNA in granulosa cells, we discovered ARHGAP4, which is a member of GTPase-activating proteins (GAPs) may be a candidate target for POR treatment. ARHGAP4 was significantly increased in poor ovarian responders and can be recovered after Cai’s Prescription pretreatment. Mechanically, combining the cell line model and clinical tissue samples, we found that ARHGAP4 can accelerate cell apoptosis and inflammation response in granulosa cells via PI3K-Akt signaling pathway. In addition, Cai’s Prescription pretreatment for three months significantly reduced the high level of ARHGAP4 in poor ovarian responders. Conclusion This study shows that the traditional Chinese medicine, Cai’s Prescription yielded satisfactory results for poor ovarian responders clinically and ARHGAP4 may be a candidate target for POR treatment.https://doi.org/10.1186/s13048-024-01363-xPoor ovarian responseTraditional Chinese medicineARHGAP4Apoptosis
spellingShingle Zheng Wang
Denghao Liu
Yonghong Nie
Qinhua Zhang
Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
Journal of Ovarian Research
Poor ovarian response
Traditional Chinese medicine
ARHGAP4
Apoptosis
title Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
title_full Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
title_fullStr Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
title_full_unstemmed Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
title_short Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
title_sort cai s prescription inhibits granulosa cell apoptosis through arhgap4 on poor ovarian responders
topic Poor ovarian response
Traditional Chinese medicine
ARHGAP4
Apoptosis
url https://doi.org/10.1186/s13048-024-01363-x
work_keys_str_mv AT zhengwang caisprescriptioninhibitsgranulosacellapoptosisthrougharhgap4onpoorovarianresponders
AT denghaoliu caisprescriptioninhibitsgranulosacellapoptosisthrougharhgap4onpoorovarianresponders
AT yonghongnie caisprescriptioninhibitsgranulosacellapoptosisthrougharhgap4onpoorovarianresponders
AT qinhuazhang caisprescriptioninhibitsgranulosacellapoptosisthrougharhgap4onpoorovarianresponders